These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9990456)

  • 1. Platelet glycoprotein IIb/IIIa receptor antagonists derived from isoxazolidines.
    Confalone PN; Jin F; Mousa SA
    Bioorg Med Chem Lett; 1999 Jan; 9(1):55-8. PubMed ID: 9990456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and pharmacology of modified amidine isoxazoline glycoprotein IIb/IIIa receptor antagonists.
    Sielecki TM; Liu J; Mousa SA; Racanelli AL; Hausner EA; Wexler RR; Olson RE
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2201-4. PubMed ID: 11514170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of action.
    Olson RE; Sielecki TM; Wityak J; Pinto DJ; Batt DG; Frietze WE; Liu J; Tobin AE; Orwat MJ; Di Meo SV; Houghton GC; Lalka GK; Mousa SA; Racanelli AL; Hausner EA; Kapil RP; Rabel SR; Thoolen MJ; Reilly TM; Anderson PS; Wexler RR
    J Med Chem; 1999 Apr; 42(7):1178-92. PubMed ID: 10197962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antiplatelet effects of an isoxazole series of glycoprotein IIb/IIIa antagonists.
    Xue CB; Roderick J; Mousa S; Olson RE; DeGrado WF
    Bioorg Med Chem Lett; 1998 Dec; 8(24):3499-504. PubMed ID: 9934460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of an orally active series of isoxazoline glycoprotein IIb/IIIa antagonists.
    Xue CB; Wityak J; Sielecki TM; Pinto DJ; Batt DG; Cain GA; Sworin M; Rockwell AL; Roderick JJ; Wang S; Orwat MJ; Frietze WE; Bostrom LL; Liu J; Higley CA; Rankin FW; Tobin AE; Emmett G; Lalka GK; Sze JY; Di Meo SV; Mousa SA; Thoolen MJ; Racanelli AL; Olson RE
    J Med Chem; 1997 Jun; 40(13):2064-84. PubMed ID: 9207948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-peptide GPIIb/IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregation.
    Egbertson MS; Cook JJ; Bednar B; Prugh JD; Bednar RA; Gaul SL; Gould RJ; Hartman GD; Homnick CF; Holahan MA; Libby LA; Lynch JJ; Lynch RJ; Sitko GR; Stranieri MT; Vassallo LM
    J Med Chem; 1999 Jul; 42(13):2409-21. PubMed ID: 10395482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ring constrained analogues of beta-alanine-containing GPIIb/IIIa receptor antagonists.
    Sielecki TM; Wityak J; Liu J; Mousa SA; Thoolen M; Wexler RR; Olson RE
    Bioorg Med Chem Lett; 2000 Mar; 10(5):449-52. PubMed ID: 10743945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of conformationally restricted benzamidines as arginine surrogates in the design of platelet GPIIb-IIIa receptor antagonists.
    Sall DJ; Arfsten AE; Bastian JA; Denney ML; Harms CS; McCowan JR; Morin JM; Rose JW; Scarborough RM; Smyth MS; Um SL; Utterback BG; Vasileff RT; Wikel JH; Wyss VL; Jakubowski JA
    J Med Chem; 1997 Aug; 40(18):2843-57. PubMed ID: 9288166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoxazoline GPIIb/IIIa antagonists bearing a phosphoramidate.
    Wityak J; Tobin AE; Mousa SA; Wexler RR; Olson RE
    Bioorg Med Chem Lett; 1999 Jan; 9(2):123-6. PubMed ID: 10021912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidomimetics - antagonists of the fibrinogen receptors: molecular design, structures, properties and therapeutic applications.
    Andronati SA; Karaseva TL; Krysko AA
    Curr Med Chem; 2004 May; 11(9):1183-211. PubMed ID: 15134514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein IIb/IIIa inhibitors increase COAT-platelet production in vitro.
    Hamilton SF; Miller MW; Thompson CA; Dale GL
    J Lab Clin Med; 2004 May; 143(5):320-6. PubMed ID: 15122176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonpeptide glycoprotein IIb/IIIa inhibitors: substituted quinazolinediones and quinazolinones as potent fibrinogen receptor antagonists.
    Liverton NJ; Armstrong DJ; Claremon DA; Remy DC; Baldwin JJ; Lynch RJ; Zhang G; Gould RJ
    Bioorg Med Chem Lett; 1998 Mar; 8(5):483-6. PubMed ID: 9871603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel antagonists of glycoprotein IIb/IIIa-mediated platelet aggregation through virtual screening.
    Wang Y; Zhao Y; Sun R; Kong W; Wang B; Yang G; Li Y
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1249-53. PubMed ID: 25677660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of clot retraction by glycoprotein IIb/IIIa antagonists.
    Seiffert D; Pedicord DL; Kieras CJ; He B; Stern AM; Billheimer JT
    Thromb Res; 2002 Nov; 108(2-3):181-9. PubMed ID: 12590956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New platelet fibrinogen receptor glycoprotein IIb-IIIa antagonists: orally active series of N-alkylated amidines with a 6,6-bicyclic template.
    Okumura K; Shimazaki T; Aoki Y; Yamashita H; Tanaka E; Banba S; Yazawa K; Kibayashi K; Banno H
    J Med Chem; 1998 Oct; 41(21):4036-52. PubMed ID: 9767641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-peptide glycoprotein IIb/IIIa inhibitors. 17. Design and synthesis of orally active, long-acting non-peptide fibrinogen receptor antagonists.
    Askew BC; Bednar RA; Bednar B; Claremon DA; Cook JJ; McIntyre CJ; Hunt CA; Gould RJ; Lynch RJ; Lynch JJ; Gaul SL; Stranieri MT; Sitko GR; Holahan MA; Glass JD; Hamill T; Gorham LM; Prueksaritanont T; Baldwin JJ; Hartman GD
    J Med Chem; 1997 Jun; 40(12):1779-88. PubMed ID: 9191954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RGD mimetics containing phthalimidine fragment as novel ligands of fibrinogen receptor.
    Krysko AA; Samoylenko GV; Polishchuk PG; Andronati SA; Kabanova TA; Khristova TM; Kuz'min VE; Kabanov VM; Krysko OL; Varnek AA; Grygorash RY
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5971-4. PubMed ID: 21852128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of potent isoxazoline glycoprotein IIb/IIIa receptor antagonists.
    Wityak J; Sielecki TM; Pinto DJ; Emmett G; Sze JY; Liu J; Tobin AE; Wang S; Jiang B; Ma P; Mousa SA; Wexler RR; Olson RE
    J Med Chem; 1997 Jan; 40(1):50-60. PubMed ID: 9016328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral antiplatelet efficacy and specificity of a novel nonpeptide platelet GPIIb/IIIa receptor antagonist, DMP 802.
    Mousa SA; Olson RE; Bozarth JM; Lorelli W; Forsythe MS; Racanelli A; Gibbs S; Schlingman K; Bozarth T; Kapil R; Wityak J; Sielecki TM; Wexler RR; Thoolen MJ; Slee A; Reilly TM; Anderson PS; Friedman PA
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):169-76. PubMed ID: 9700976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of a series of indole glycoprotein IIb/IIIa inhibitors.
    Grumel V; Mérour JY; Lesur B; Giboulot T; Frydman A; Guillaumet G
    Eur J Med Chem; 2002 Jan; 37(1):45-62. PubMed ID: 11841874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.